128 related articles for article (PubMed ID: 25974720)
1. Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy.
Moore W; Chaya Y; Chaudhry A; Depasquale B; Glass S; Lee S; Shin J; Mikhail G; Bhattacharji P; Kim B; Bilfinger T
J Comput Assist Tomogr; 2015; 39(5):804-9. PubMed ID: 25974720
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
5. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer.
Huang K; Senthi S; Palma DA; Spoelstra FO; Warner A; Slotman BJ; Senan S
Radiother Oncol; 2013 Oct; 109(1):51-7. PubMed ID: 23953413
[TBL] [Abstract][Full Text] [Related]
6. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
[TBL] [Abstract][Full Text] [Related]
7. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Med Phys; 2014 Mar; 41(3):033502. PubMed ID: 24593744
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
[TBL] [Abstract][Full Text] [Related]
11. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
[TBL] [Abstract][Full Text] [Related]
12. CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy.
Sawyer B; Pun E; Samuel M; Tay H; Kron T; Bressel M; Ball D; Siva S
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):207-15. PubMed ID: 25601133
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
14. Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Ronden MI; van Sörnsen de Koste JR; Johnson C; Slotman BJ; Spoelstra FOB; Haasbeek CJA; Blom G; Bongers EM; Warner A; Ward A; Palma D; Senan S
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):115-121. PubMed ID: 29102278
[TBL] [Abstract][Full Text] [Related]
15. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.
Takeda A; Kunieda E; Takeda T; Tanaka M; Sanuki N; Fujii H; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1057-65. PubMed ID: 17905527
[TBL] [Abstract][Full Text] [Related]
16. Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques.
Senthi S; Dahele M; van de Ven PM; Slotman BJ; Senan S
Radiother Oncol; 2013 Oct; 109(1):77-81. PubMed ID: 24060174
[TBL] [Abstract][Full Text] [Related]
17. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.
Huang K; Dahele M; Senan S; Guckenberger M; Rodrigues GB; Ward A; Boldt RG; Palma DA
Radiother Oncol; 2012 Mar; 102(3):335-42. PubMed ID: 22305958
[TBL] [Abstract][Full Text] [Related]
18. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.
Griffioen GH; Lagerwaard FJ; Haasbeek CJ; Smit EF; Slotman BJ; Senan S
Radiother Oncol; 2013 Jun; 107(3):403-8. PubMed ID: 23746675
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease.
Verstegen NE; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Radiother Oncol; 2011 Nov; 101(2):250-4. PubMed ID: 22056535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
